Startup Creator Launched to Fill Europe’s Microbiome Translational Gap
With a €49M ($60M) Series A, the French firm eureKARE debuted this month with the…
With a €49M ($60M) Series A, the French firm eureKARE debuted this month with the…
Stock markets worldwide have experienced painful instability in the last few months. As a result,…
Europe is seeing a surge of interest in edible insect farming after an EU vote…
As the EU phases out a wide range of single-use plastics this year, investor interest…
The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for…
Last month, the US firm bluebird bio abandoned the sale of its gene therapy Zynteglo…
Bristol Myers Squibb’s recent phase III success provided the first late-stage confirmation for a novel…
While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations…
Last month’s EU approval of Vazkepa -- a treatment derived from fish oil and branded…
The US medtech firm Hologic has bought the Finnish-French biotech Mobidiag for around €668M in…
The close of the UK firm Achilles Therapeutics’ €146.9M ($175.5M) initial public offering last month…
Last year, the FDA rejected DBV Technologies’ peanut allergy treatment and approved that of its…